Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412640
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-05-09
Brief Title:
Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Organization Data
Organization:
Nanjing First Hospital Nanjing Medical University
Class:
OTHER
Study ID:
KY20240419-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanjing First Hospital Nanjing Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhenyu Zhang
Responsible Party Title:
Director of Gastroenterology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanjing First Hospital Nanjing Medical University
Old Name:
None
Old Organization:
None